Highest-materiality recent filing
All four Class II director nominees elected: DeAngelo, Hughes, James, Knott; broker non-votes 11,958,426.
GPGI reincorporates from Delaware to Nevada; effective June 5, 2026
Each share of Delaware Class A common stock converted 1-for-1 into Nevada common stock; ticker unchanged (GPGI).
Shareholders approve reincorporation from Delaware to Nevada at June 4 special meeting
59.2% voted for, 33.2% against, 147,411 abstentions; 92% quorum of 289,861,033 shares.
GPGI Q1: GAAP net loss $235M; pro forma adj. EBITDA -16% on Husky headwinds
GAAP net loss of $235.0M; pro forma adj. EBITDA $82.1M, down 16% YoY; margin 19.5%, down 430 bps.
GPGI Executive Chairman Dave Cote to speak at J.P. Morgan Industrials Conference
Dave Cote participates in fireside chat at J.P. Morgan Industrials Conference on March 16, 2026 at 1:45 p.m. EDT.
GPGI Q4 2025 organic revenue up 17%, Pro Forma Adj. EBITDA up 41%; guides FY26
Q4 2025 non-GAAP net sales $118M (+17% YoY); GAAP net income $43.3M vs loss of $48.4M in Q4 2024.
GPGI declares $0.0025/share quarterly dividend; annual distribution ~$2.9M
Cash dividend of $0.0025 per Class A common share declared by Board.
CEO Jonathan Wilk departs effective Jan 21, 2026; Graham Robinson named President & CEO of CompoSecure segment effective Jan 22.
Refinanced ~$2.1B aggregate principal debt following Jan 13, 2026 combination with Husky Technologies.
CompoSecure files registration for resale of 161M shares by selling stockholders
Prospectus supplement filed Jan 14, 2026 for resale of 161,034,417 shares of common stock by selling stockholders.
CompoSecure closes $7.4B Husky acquisition; rebrands to GPGI, Inc.
Combined company valued at $7.4B, ~11.6x 2026E Pro Forma Adj. EBITDA of ~$635M; deal >20% accretive to adj. diluted EPS.
CompoSecure shareholders approve stock issuance for Husky deal; close expected Jan 2026
Stockholders approved the stock issuance proposal with 99.97% in favor (105,725,145 for, 21,482 against, 61,903 abstain).
CompoSecure adds proxy statement disclosures for Husky deal after shareholder lawsuits
Three shareholder lawsuits filed in NY and NJ alleging proxy statement omissions; company denies merit but voluntarily supplements.
CompoSecure to acquire Husky Technologies for ~$3.95B in cash and stock, plus $1.96B PIPE
Aggregate consideration $3.953B: cash plus 55,297,297 shares of CMPO common stock.
CompoSecure to combine with Husky Technologies for ~$4.976B; $1.96B PIPE at $18.50/sh
Total consideration ~$4.976B in cash and CMPO stock; Husky becomes wholly owned subsidiary.
Redemption price is $0.01 per warrant; warrants must be exercised by 5:00 p.m. ET on December 3, 2025.
CompoSecure Q3 non-GAAP sales $120.9M (+13%), raises FY25 guidance, buys Husky for ~$5B
Q3 Non-GAAP net sales $120.9M (+13% YoY); gross margin 59.0% vs 51.7%; Pro Forma Adj. EBITDA $47.7M (+30%).
CompoSecure appoints Mary Holt as CFO, succeeding retiring Tim Fitzsimmons
Mary Holt appointed CFO effective after Q3 2025 10-Q filing; succeeds Tim Fitzsimmons (retiring).
CompoSecure issues 4.3M shares after second earnout threshold achieved Sept 8, 2025
Second phase earnout triggered on Sept 8, 2025; 4.3M Class A shares issued to eligible parties.
Class A common stock (CMPO) will begin trading on NYSE on September 23, 2025.
CompoSecure Q2 non-GAAP net sales up 10% YoY to $119.6M; raises FY2025 guidance
Non-GAAP net sales $119.6M (+10% YoY); gross margin expanded to 57.5% from 51.6%.
CompoSecure CFO Timothy Fitzsimmons to retire; successor search underway, transition by Jan 1, 2026
CFO Timothy Fitzsimmons will retire upon appointment of successor, expected H2 2025 but no later than Jan 1, 2026.
CompoSecure appoints Rebecca Corbin Loree and Kevin Moriarty to board; amends governance agreement
Rebecca Corbin Loree and Kevin Moriarty appointed to CompoSecure board effective July 12, 2025.
CompoSecure appoints Rebecca Corbin Loree and Kevin Moriarty to Board of Directors
Appointed effective July 12, 2025; both are independent directors.
CompoSecure CFO Tim Fitzsimmons to retire; successor search underway; FY2025 guidance reaffirmed
CFO Tim Fitzsimmons will retire once successor assumes role, expected H2 2025 but no later than Jan 1, 2026.
Authorized Class A common stock increased from 250M to 1B shares; amendment effective upon filing with Delaware.
CompoSecure Q1 Non‑GAAP net sales $103.9M flat YoY; adjusted EPS $0.25; reiterates FY2025 guide
GAAP net sales $59.8M (partial period after Resolute Holdings spin‑off on Feb 28); GAAP diluted EPS $0.07.
CompoSecure board values Resolute Holdings spin-off at $106.4M ($12.48/share)
Board approved $106.4 million fair market value for Resolute Holdings shares distributed in Spin-Off.
CompoSecure completes spin-off of Resolute Holdings; RHLD begins trading on Nasdaq
Holders of CMPO common stock received 1 share of Resolute Holdings (RHLD) for every 12 shares held as of Feb 20, 2025.
FY net sales $420.6M (+8% YoY); Q4 net sales $100.9M (+1% YoY).
CompoSecure completes spin-off of Resolute Holdings; warrant price adjusted to $7.97
Distribution on Feb 28, 2025: 1 share of Resolute Holdings per 12 shares of CMPO held on record date Feb 20, 2025.
CompoSecure completes spin-off of Resolute Holdings; distribution ratio 1:12
Spin-off effective 12:01 a.m. ET on Feb 28, 2025.
CompoSecure sets Feb 28 spin-off of Resolute Holdings; prelim FY2024 rev $420.6M in line
Record date Feb 20, 2025; distribution ratio 1 share RHLD per 12 CMPO shares; expected to trade under 'RHLD'.
CompoSecure amends credit agreement to permit spin-off of Resolute Holdings
Spin-off of Resolute Holdings to occur no later than Feb 28, 2025; conditions include no default and delivery of certificate.
CompoSecure plans spin-off of Resolute Holdings to shareholders; taxable, expected Q1 2025
Pro rata distribution of Resolute Holdings shares to all CompoSecure shareholders; expected to trade under 'RHLD' on Nasdaq.
CompoSecure issues 3.6M shares after achieving $15 VWAP earn-out threshold
Issued 3.6 million shares of Class A common stock on Dec 17, 2024.
CompoSecure converts all $130M exchangeable notes to equity, reducing debt by $130M
All $130M of 7.00% Exchangeable Notes due 2026 exchanged for Class A common stock; no Notes remain outstanding.
CompoSecure eliminates dual-class structure, adopts Third Amended LLC Agreement
On November 21, 2024, CompoSecure entered Third Amended LLC Agreement for CompoSecure Holdings.
Q3 2024 net sales $107.1M, up 11% YoY; GAAP net loss $85.5M from stock price impact on non-cash items.
CompoSecure appoints Dr. Krishna Mikkilineni to Board, replaces Niloo Razi Howe
Appointed effective Oct 18, 2024 as Class III director, term expiring 2027.
CompoSecure director Niloofar Razi Howe resigns effective Sep 30, 2024
Niloofar Razi Howe resigned from CompoSecure's Board effective September 30, 2024, for personal reasons.
Effective Sep 19, 2024, exchange rate on 7.00% Notes due 2026 increased from 91.0972 to 104.5199 shares of CMPO common per $1,000 principal.
Resolute acquires 60% voting interest in CompoSecure for $372.1M; board expanded to 11
Resolute Compo Holdings paid $7.55/share for 49.29M shares of Class A common stock, acquiring ~60% voting interest.
Resolute led by David Cote acquires majority of CompoSecure; new $330M credit facility
Resolute (David Cote, Tom Knott) buys 49,290,409 Class A shares from LLR, Logan, and Wilk LLC, gaining majority control.
CompoSecure Q2 sales hit record $108.6M; Resolute to acquire majority for $372M
Q2 net sales $108.6M (+10% YoY); net income $33.6M (+3%); adj. EBITDA $40.0M (+8%).
CompoSecure stockholders elect three Class III directors, ratify Grant Thornton as auditor
Mitchell Hollin elected with 68,498,356 votes for, 4,442,326 withheld; 2,462,279 broker non-votes.
CompoSecure secondary offering of 7M shares priced at $6.50; over-allotment exercised
7,000,000 shares of Class A common stock sold by selling stockholders at $6.50/share, gross proceeds $45.5M.
CompoSecure reports record Q1 revenue, declares special dividend of $0.30/share
Q1 net sales $104.0M (+9% YoY), net income $17.1M (+59% YoY), adjusted EBITDA $37.8M (+6% YoY).
CompoSecure Q4 net sales $99.9M (+7% YoY), net income $31M (+39%); $40M buyback
Q4 net sales $99.9M (+7% YoY); net income $31M (+39%); adjusted EBITDA $37.2M (+22%).
CompoSecure cuts FY2023 sales guidance to $386-392M; Q3 net sales down 6% YoY
Q3 Net Sales $96.9M vs $103.3M YoY; Gross Profit margin 50.5% vs 59.8% on inflation and production inefficiencies.
On June 10, 2025, Timothy Fitzsimmons, Chief Financial Officer (“CFO”) of CompoSecure, Inc. (the “Company”) informed the Company’s Board of Directors that he will retire from his position
On February 28, 2025, Roger Fradin notified the Company of his decision to resign as a director of the Board, effective immediately.
On October 18, 2024, the Board of Directors (the “Board”) of CompoSecure, Inc. (the “Company”) appointed Dr. Krisha Mikkilineni to fill the vacancy created by the previously announced retirement of Niloofar Razi Howe.
On October 18, 2024, the Board of Directors (the “Board”) of CompoSecure, Inc. (the “Company”) appointed Dr. Krisha Mikkilineni to fill the vacancy created by the previously announced retirement of Niloofar Razi Howe.
On September 29, 2024, Niloofar Razi Howe notified CompoSecure, Inc. (the “Company”) of her decision to resign as a director of the Company’s Board of Directors (the “Board”), effective September 30, 2024.
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
on August 7, 2024, each of Mitchell Hollin and Michele Logan delivered notice of their resignation as a member of the Board and all committees thereof, subject to and contingent on the consummation of the Closing, pursuant to the terms of the Letter Agreement.
On September 21, 2022, Roman designated Paul S. Galant to serve as a director on the Board and on September 21, 2022, the Board elected Mr. Galant to serve on the Board, effective immediately
Dr. Donald Basile notified the Board of Directors (the “Board”) of CompoSecure, Inc. (the “Company”) that he had resigned from the Board, effective as of 8:59 A.M. ET on September 21, 2022.
Max materiality 1.00 · Median 0.65 · Most common event other_material